Cargando…

Assessing and Managing the Metabolic Syndrome in Children and Adolescents

The metabolic syndrome (MetS) is a group of cardiovascular risk factors that are associated with insulin resistance and are driven by underlying factors, including visceral obesity, systemic inflammation, and cellular dysfunction. These risks increasingly begin in childhood and adolescence and are a...

Descripción completa

Detalles Bibliográficos
Autor principal: DeBoer, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723651/
https://www.ncbi.nlm.nih.gov/pubmed/31382417
http://dx.doi.org/10.3390/nu11081788
_version_ 1783448819477774336
author DeBoer, Mark D.
author_facet DeBoer, Mark D.
author_sort DeBoer, Mark D.
collection PubMed
description The metabolic syndrome (MetS) is a group of cardiovascular risk factors that are associated with insulin resistance and are driven by underlying factors, including visceral obesity, systemic inflammation, and cellular dysfunction. These risks increasingly begin in childhood and adolescence and are associated with a high likelihood of future chronic disease in adulthood. Efforts should be made at both recognition of this metabolic risk, screening for potential associated Type 2 diabetes, and targeting affected individuals for appropriate treatment with an emphasis on lifestyle modification. Effective interventions have been linked to reductions in MetS—and in adults, reductions in the severity of MetS have been linked to reduced diabetes and cardiovascular disease.
format Online
Article
Text
id pubmed-6723651
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67236512019-09-10 Assessing and Managing the Metabolic Syndrome in Children and Adolescents DeBoer, Mark D. Nutrients Communication The metabolic syndrome (MetS) is a group of cardiovascular risk factors that are associated with insulin resistance and are driven by underlying factors, including visceral obesity, systemic inflammation, and cellular dysfunction. These risks increasingly begin in childhood and adolescence and are associated with a high likelihood of future chronic disease in adulthood. Efforts should be made at both recognition of this metabolic risk, screening for potential associated Type 2 diabetes, and targeting affected individuals for appropriate treatment with an emphasis on lifestyle modification. Effective interventions have been linked to reductions in MetS—and in adults, reductions in the severity of MetS have been linked to reduced diabetes and cardiovascular disease. MDPI 2019-08-02 /pmc/articles/PMC6723651/ /pubmed/31382417 http://dx.doi.org/10.3390/nu11081788 Text en © 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
DeBoer, Mark D.
Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title_full Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title_fullStr Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title_full_unstemmed Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title_short Assessing and Managing the Metabolic Syndrome in Children and Adolescents
title_sort assessing and managing the metabolic syndrome in children and adolescents
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723651/
https://www.ncbi.nlm.nih.gov/pubmed/31382417
http://dx.doi.org/10.3390/nu11081788
work_keys_str_mv AT deboermarkd assessingandmanagingthemetabolicsyndromeinchildrenandadolescents